CVS Health (NYSE:CVS) updated its FY18 earnings guidance on Tuesday. The company provided earnings per share guidance of $6.98-7.08 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $7.04. CVS Health also updated its FY 2018 guidance to $6.98-7.08 EPS.
CVS has been the subject of a number of recent research reports. Wolfe Research initiated coverage on CVS Health in a research report on Thursday, October 25th. They set a peer perform rating for the company. Leerink Swann set a $80.00 price objective on CVS Health and gave the company an outperform rating in a research report on Thursday, August 9th. Royal Bank of Canada set a $99.00 price objective on CVS Health and gave the company a buy rating in a research report on Tuesday, October 23rd. Citigroup reiterated a buy rating and set a $81.00 price objective on shares of CVS Health in a research report on Monday, July 9th. Finally, ValuEngine downgraded CVS Health from a sell rating to a strong sell rating in a research report on Tuesday, September 4th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating, ten have issued a buy rating and two have issued a strong buy rating to the company’s stock. CVS Health presently has a consensus rating of Buy and an average price target of $86.18.
NYSE:CVS traded up $3.65 during trading hours on Tuesday, hitting $77.34. 897,064 shares of the stock traded hands, compared to its average volume of 7,920,882. The company has a quick ratio of 1.87, a current ratio of 2.34 and a debt-to-equity ratio of 1.73. CVS Health has a fifty-two week low of $60.14 and a fifty-two week high of $83.88. The company has a market cap of $74.41 billion, a P/E ratio of 13.11, a price-to-earnings-growth ratio of 0.97 and a beta of 0.98.
CVS Health (NYSE:CVS) last announced its earnings results on Tuesday, November 6th. The pharmacy operator reported $1.73 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.02. CVS Health had a net margin of 1.61% and a return on equity of 18.25%. The company had revenue of $47.27 billion for the quarter, compared to the consensus estimate of $47.22 billion. During the same period in the previous year, the business earned $1.50 EPS. The company’s revenue was up 2.4% on a year-over-year basis. Equities research analysts anticipate that CVS Health will post 7.05 earnings per share for the current year.
The company also recently announced a quarterly dividend, which was paid on Thursday, November 1st. Shareholders of record on Wednesday, October 24th were paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.59%. The ex-dividend date was Tuesday, October 23rd. CVS Health’s dividend payout ratio (DPR) is currently 33.90%.
In other CVS Health news, EVP Kevin Hourican sold 8,564 shares of the business’s stock in a transaction on Monday, August 27th. The shares were sold at an average price of $75.00, for a total transaction of $642,300.00. Following the sale, the executive vice president now directly owns 12,135 shares of the company’s stock, valued at approximately $910,125. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Eva C. Boratto sold 13,311 shares of the business’s stock in a transaction on Monday, September 17th. The shares were sold at an average price of $77.16, for a total transaction of $1,027,076.76. Following the sale, the executive vice president now directly owns 55,162 shares in the company, valued at $4,256,299.92. The disclosure for this sale can be found here. Over the last three months, insiders have sold 43,409 shares of company stock worth $3,392,097. Company insiders own 0.53% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This piece was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece on another site, it was stolen and reposted in violation of United States and international trademark & copyright legislation. The correct version of this piece can be accessed at https://www.dispatchtribunal.com/2018/11/06/cvs-health-cvs-updates-fy18-earnings-guidance.html.
CVS Health Company Profile
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.
Featured Story: Understanding Market Liquidity
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.